FDA CDER 报告与预算页面汇总:各办公室与部门报告及预算
Reports & Budgets | CDER
美国 FDA 药品评价与研究中心(CDER)的报告与预算页面汇总了其各办公室和部门的预算与报告,包括预算摘要、科学进展报告及用户付费协议报告。页面列出 PDUFA 与 GDUFA 年度报告和计划、新药疗法批准报告、Drug Trials Snapshots 摘要报告等。页面内容截至 2026 年 5 月 20 日。
An official website of the United States governmentHere’s how you know
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
- Search
- Menu
Search FDA Submit search
Featured
- Report a Product Problem
- Contact FDA
- FDA Guidance Documents
- Recalls, Market Withdrawals and Safety Alerts
- Press Announcements
- Warning Letters
- Advisory Committees
- En Español
Products
- Food
- Drugs
- Medical Devices
- Radiation-Emitting Products
- Vaccines, Blood, and Biologics
- Animal and Veterinary
- Cosmetics
- Tobacco Products
Topics
- About FDA
- Combination Products
- Regulatory Information
- Safety
- Emergency Preparedness
- International Programs
- News and Events
- Training and Continuing Education
- Inspections and Compliance
- Science and Research
Information For
Reports & Budgets | CDER
Reports and budgets from CDER offices and divisions
Budgets
Reports
Scientific Progress from CDER Offices and Divisions
- Office of Translational Sciences 2022 Annual Report
- Office of Clinical Pharmacology Annual Reports
- Division of Applied Regulatory Science Annual Reports
- Office of Pharmaceutical Quality Annual Reports
- Office of Generic Drugs FYs 2013 - 2017 Regulatory Science Research Report
- Office of New Drugs Annual Reports
User Fee Agreement Reports
- Prescription Drug User Fee Act (PDUFA) Annual Reports and Plans
- Generic Drug User Fee Amendments (GDUFA) Annual Reports and Plans
New Approvals Reports
Additional Reports
Workshop Report: Enhancing Clinical Study Diversity| June 2024 (PDF - 624 KB)
Meeting Report: Mitigating Clinical Study Disruptions During Disasters and Public Health Emergencies| January 2024 (PDF - 279 KB)
Report to Congress: The Listing of Patent Information in the Orange Book| December 2021
Advances in FDA's Drug Safety Programs(annual reports)
Source Data Capture from Electronic Health Records (EHRs): Using Standardized Clinical Research Data
FDA's Human Drug Compounding Progress Report: Three Years After Enactment of the Drug Quality and Security Act| January 2017
The Voice of the Patient: A Series of Reports from FDA's Patient-Focused Drug Development Initiative
Content current as of:
05/20/2026 *
Regulated Product(s)
* Drugs
Feedback
Contact FDAFollow FDA on FacebookFollow FDA on XFollow FDA on Instagram
Follow FDA on LinkedInView FDA videos on YouTubeSubscribe to FDA RSS feeds
Contact Number 1-888-INFO-FDA (1-888-463-6332)
来源:FDA 官方药品与生物制品信息 · fda.gov